ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

ClinicalTrials.gov ID: NCT07332091

Public ClinicalTrials.gov record NCT07332091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 12:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study of the Efficacy and Safety of Vamifeport in Adult Subjects With HFE-related Hereditary Hemochromatosis (FERROCLEAR Study)

Study identification

NCT ID
NCT07332091
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
CSL Behring
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Vamifeport Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 21, 2026
Primary completion
Mar 5, 2028
Completion
Apr 5, 2028
Last update posted
Mar 26, 2026

2026 – 2028

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Banner MD Anderson Gilbert Arizona 85234-2165 Not yet recruiting
Infinity Clinical Trials San Diego California 92108 Not yet recruiting
Medical Oncology Associates of San Diego San Diego California 92123 Not yet recruiting
Green Leaf Clinical Trials Jacksonville Florida 32258 Recruiting
Indiana University Health University Hospital Indianapolis Indiana 46202-5149 Not yet recruiting
Ochsner Medical Complex - High Grove Baton Rouge Louisiana 70836 Not yet recruiting
Johns Hopkins University School of Medicine Baltimore Maryland 21205 Not yet recruiting
American Oncology Partners, PA dba The Center for Cancer and Blood Disorders Bethesda Maryland 20817 Not yet recruiting
James M. Stockman Cancer Institute Frederick Maryland 21702-4337 Not yet recruiting
University of Michigan Health System (UMHS) Ann Arbor Michigan 48109 Not yet recruiting
Aspirus St. Luke's Clinic - Duluth - Oncology & Hematology Duluth Minnesota 55805 Not yet recruiting
Hunterdon Hematology Oncology, LLC Flemington New Jersey 08822 Not yet recruiting
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27517-7518 Not yet recruiting
Duke University Medical Center (Duke South Clinics) -40 Duke Medicine Cir Durham North Carolina 27710-4000 Not yet recruiting
Hightower Clinical - Oklahoma Cancer Center Oklahoma City Oklahoma 73174 Not yet recruiting
Intermountain Medical Center Murray Utah 84107 Not yet recruiting
Washington State Univ Elson S. Floyd College of Medicine Spokane Washington 99202-2131 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07332091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07332091 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →